Two of them were rejected after deep analysis due to the lack of clear information about statistical significance in the E-cadherin staining between grades 1, 2, and 3 of ovarian cancer [47] and the examination of its expression in relation to tumor grading and patient survival together [31]. This evidence concerns the gene CDH1 and ovarian cancer.